All In Biotech

Drug Trial Radar · NCT07832136

An Open-Label Trial of Veligrotug in Participants With Thyroid Eye Disease Who Previously Responded to Teprotumumab

A Phase 4, Single-Arm, Open-Label Trial to Evaluate the Safety and Efficacy of Veligrotug in Participants With Thyroid Eye Disease (TED) Who Previously Responded to Teprotumumab

Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Apr 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Viridian Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 21, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical trial to evaluate the safety and efficacy of veligrotug (LUMVOA™) in participants with moderate to severe TED who previously received and responded to an initial course of teprotumumab treatment but subsequently had a disease recurrence.

Conditions

  • Thyroid Eye Disease

Interventions

  • veligrotrug (LUMVOA™)Drug

    intravenous infusions

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of veligrotrug (LUMVOA™)Time frame: Through Week 15

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Office of Dr. Amy Patel Jain, MD

    Newport Beach, California

  • Sarasota Retina Institute

    Sarasota, Florida

  • Ophthalmic Consultants of Boston

    East Weymouth, Massachusetts

  • Kahana Oculoplastic & Orbital Surgery

    Livonia, Michigan

  • University Health

    Kansas City, Missouri

  • The Center for Eye and Facial Plastic Surgery

    Somerset, New Jersey

  • Neuro-Eye Clinical Trials

    Houston, Texas

  • Baylor College of Medicine Alkek Eye Center

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.